Champions Oncology, Inc.CSBRNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P73
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | -1.55% | -114.0% |
| 2025 | 11.05% | +202.4% |
| 2024 | -10.79% | -181.0% |
| 2023 | -3.84% | -163.0% |
| 2022 | 6.10% | +24.0% |
| 2021 | 4.92% | +315.0% |
| 2020 | -2.29% | -174.0% |
| 2019 | 3.09% | +157.8% |
| 2018 | -5.35% | +87.7% |
| 2017 | -43.46% | - |